MedPath

NEOGAP Therapeutics AB

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Phase 1
Recruiting
Conditions
Colorectal Cancer
Interventions
Drug: pTTL
First Posted Date
2023-06-18
Last Posted Date
2025-05-29
Lead Sponsor
Neogap Therapeutics AB
Target Recruit Count
16
Registration Number
NCT05908643
Locations
🇸🇪

Medical Unit Cell therapy and Allogeneic Stem cell Transplantation (ME CAST), and the Center for Clinical Cancer studies - Phase 1 unit, Karolinska University Hospital, Stockholm, Sweden

🇸🇪

Unit for Colorectal Surgery, Dept. of Surgery, Västmanlands Sjukhus Västerås, Västerås, Sweden

News

No news found
© Copyright 2025. All Rights Reserved by MedPath